Albany,New York (PRWEB) May 29, 2014
ResearchMoz.us includes new market research report "EpiCast Report: Multiple Sclerosis - Epidemiology Forecast to 2023" to its huge collection of research reports.
Multiple sclerosis (MS) is an inflammatory disease in which the myelin sheaths around the axons of the brain and spinal cord are damaged, leading to demyelination and a wide range of signs and symptoms. MS affects 2.5 million people worldwide each year and is the most debilitating neurological disease in young adults.
Detailed Report With TOC @ http://www.researchmoz.us/epicast-report-multiple-sclerosis-epidemiology-forecast-to-2023-report.html
Epidemiologists expect that the number of prevalent and incident cases of MS will increase during the forecast period (20132023) in the 10MM. In 2013, epidemiologists forecast that there were a total of 904,908 prevalent cases of MS in the 10MM, and by 2023 epidemiologists forecast that the number of prevalent cases will grow to 940,413 prevalent cases. During the forecast period, India will have the highest annual growth rate (AGR) at 1.99%, Spain will have the second highest (AGR: 1.05%), and China will have the third highest (AGR: 0.93%).
Epidemiologists used country-specific sources published by peer-reviewed journals to estimate the incidence and prevalence of MS in each of the 10MM. To provide a thorough description of the MS patient population in each country, GlobalData epidemiologists segmented MS incident and prevalent cases by age and sex, both of which strongly affect the epidemiology of MS. Moreover, cases are segmented into three common subtypes: relapsing/remitting MS, primary progressive MS, and secondary progressive MS. A major strength of this analysis is that the forecast methodology was consistent across the 10MM to allow for a meaningful comparison of the patient populations in each country.
Browse healthcare-related research reports @ http://www.researchmoz.us/healthcare-market-reports-56.html.
The Multiple Sclerosis (MS) EpiCast Report provides an overview of the risk factors and comorbidities and global and historical trends of MS in the 10 major markets (10MM) (the US, France, Germany, Italy, Spain, the UK, Japan, Canada, China and India). It includes a 10-year epidemiological forecast of MS prevalent and incident cases segmented by sex and age (in five-year increments beginning at 20 years and ending at =85 years) in these markets.
The MS epidemiology report is written and developed by Masters and PhDlevel epidemiologists.
The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 10MM.
For latest market research reports, visit http://www.researchmoz.us/latest-report.html.
Reasons to buy
Develop business strategies by understanding the trends shaping and driving the global MS market.
Quantify patient populations in the global MS market to improve product design, pricing, and launch plans.
Organize sales and marketing efforts by identifying the sex and age groups that present the best opportunities for MS therapeutics in each of the markets covered.
Table of content
1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 6
1.2 List of Figures 6
2.2 Upcoming Reports
Browse upcoming market research reports @ http://www.researchmoz.us/upcoming-report.html.
ResearchMoz is the one-stop online destination to find and buy market research reports. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets.
Our research coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. We provide the market context, competitor insight and future trends needed for strategic planning.
For more information, contact:
90 Sate Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-997-4948